CVE-2026-5781An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their…
Updated under an hour ago ()
Does this affect you?
It affects agilonhealth minerva. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.
- CVSS
- 8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-285
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
agilonhealth minerva agilonhealth:minerva | 3.6.0 | NVD |
References
- https://www.incibe.es/en/incibe-cert/notices/aviso/multiple-vulnerabilities-mphrxs-minervathird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.